Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Relapsing Forms of Multiple Sclerosis”

102 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 102 results

Large-scale testing (Phase 3)Study completedNCT01201356
What this trial is testing

Long-term Safety and Tolerability of 0.5 mg Fingolimod in Patients With Relapsing Forms of Multiple Sclerosis

Who this might be right for
Relapsing Forms of Multiple Sclerosis
Novartis Pharmaceuticals 4,125
Large-scale testing (Phase 3)Not Yet RecruitingNCT07483632
What this trial is testing

Learn About the Safety of Diroximel Fumarate (DRF) and Dimethyl Fumarate (DMF) and Their Effects on Relapses in Pediatric Participants With Relapsing Forms of Multiple Sclerosis (RMS)

Who this might be right for
Relapsing Forms of Multiple Sclerosis
Biogen 185
Not applicableUnknownNCT00914758
What this trial is testing

Comparison of Campath and Rebif Treatment on Cognition in Multiple Sclerosis (MS)

Who this might be right for
Relapsing Remitting Multiple Sclerosis
Washington Neuropsychology Research Group 1
Testing effectiveness (Phase 2)Study completedNCT05798520
What this trial is testing

Learn About the Safety of BIIB091 and Its Effect on Brain Inflammation When Taken Alone or With Diroximel Fumarate (DRF) in Adults With Relapsing Forms of Multiple Sclerosis (MS)

Who this might be right for
Relapsing Forms of Multiple Sclerosis
Biogen 127
Not applicableEnded earlyNCT04746976
What this trial is testing

Study of Diroximel Fumarate in the Real-World Setting

Who this might be right for
Relapsing Forms of MS
Biogen 75
Testing effectiveness (Phase 2)Ended earlyNCT05049161
What this trial is testing

A Long-term Extension of Study GNC-401

Who this might be right for
Multiple Sclerosis
GeNeuro Innovation SAS 33
Large-scale testing (Phase 3)Study completedNCT01199861
What this trial is testing

Effect of Treatment With Fingolimod on the Immune Response Following Seasonal Flu Vaccination and Tetanus Booster Injection in Patients With Relapsing Multiple Sclerosis (MS)

Who this might be right for
Relapsing Multiple Sclerosis
Novartis 138
Early research (Phase 1)Ended earlyNCT01318421
What this trial is testing

ELND002 in Patients With Relapsing Forms of Multiple Sclerosis

Who this might be right for
Multiple Sclerosis
Elan Pharmaceuticals 12
Large-scale testing (Phase 3)Study completedNCT04121221
What this trial is testing

Asses Efficacy, Safety and Tolerability of Monthly Long-acting IM Injection of GA Depot in Subjects With RMS

Who this might be right for
Multiple Sclerosis, Relapsing-Remitting
Mapi Pharma Ltd. 1,016
Testing effectiveness (Phase 2)Ended earlyNCT01950234
What this trial is testing

ACTH in Progressive Forms of MS

Who this might be right for
Secondary Progressive Multiple SclerosisPrimary Progressive Multiple SclerosisProgressive Relapsing Multiple Sclerosis
University of Minnesota 59
Early research (Phase 1)Ended earlyNCT02606630
What this trial is testing

[11C]-PBR28 Positron Emission Tomography Study to Evaluate the Effect of ABT 555 in Subjects With Relapsing Forms of Multiple Sclerosis

Who this might be right for
Multiple Sclerosis
AbbVie 4
Not applicableStudy completedNCT06251986
What this trial is testing

A Cross-sectional Study to Assess the Effectiveness and Safety of Ofatumumab (Kesimpta®) in Patients With Relapsing Multiple Sclerosis in the Spanish Clinical Practice

Who this might be right for
Relapsing Forms of Multiple Sclerosis
Novartis Pharmaceuticals 310
Not applicableStudy completedNCT01141751
What this trial is testing

An Observational Study Comparing Multiple Sclerosis International Quality of Life Questionnaire (MusiQoL) and Multiple Sclerosis Quality of Life-54 Instrument (MSQOL-54) in Relapsing Multiple Sclerosis (RMS) Patients on Long-term Rebif® Therapy

Who this might be right for
Multiple Sclerosis, Relapsing-Remitting
Merck KGaA, Darmstadt, Germany 334
Early research (Phase 1)Study completedNCT02601885
What this trial is testing

A Multiple Dose Study of ABT-555 in Subjects With Relapsing Forms of Multiple Sclerosis

Who this might be right for
Multiple Sclerosis
AbbVie 20
Post-approval studies (Phase 4)Study completedNCT03589105
What this trial is testing

Provide Complementary Efficacy, Safety and Patient Reported Outcomes Data in Participants With Active Relapsing Forms of Multiple Sclerosis (MS) in a Pragmatic Setting

Who this might be right for
Multiple Sclerosis
Hoffmann-La Roche 423
Not applicableUnknownNCT01811290
What this trial is testing

A Pilot Study Assessing the Impact of Gilenya Therapy on Bone Density Change in Relapsing Forms of Multiple Sclerosis

Who this might be right for
Multiple Sclerosis
Simnad, Virginia, M.D. 36
Large-scale testing (Phase 3)Study completedNCT00110396
What this trial is testing

Rebif New Formulation (RNF) in Relapsing Forms of Multiple Sclerosis

Who this might be right for
Multiple Sclerosis
EMD Serono 260
Testing effectiveness (Phase 2)Study completedNCT01569451
What this trial is testing

Comparison of Rituximab Induction Therapy Followed by Glatiramer Acetate

Who this might be right for
Multiple Sclerosis
University of Colorado, Denver 53
Large-scale testing (Phase 3)Study completedNCT05028634
What this trial is testing

Safety Study to Evaluate Immune Response of Vaccines in Participants With Relapsing Forms of Multiple Sclerosis Who Receive Ozanimod Compared to Non-Pegylated Interferon (IFN)-β or No Disease Modifying Therapy

Who this might be right for
Multiple SclerosisMultiple Sclerosis, Relapsing-Remitting
Celgene 63
Not applicableStudy completedNCT01070836
What this trial is testing

JC Virus Antibody Study of Participants With Relapsing Forms of MS Receiving Treatment With Natalizumab

Who this might be right for
Relapsing Multiple Sclerosis
Biogen 35,895
Load More Results